Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States

• Abstract
• Lay summary
• Supplementary data

Artificial Intelligence for Classification of Endoscopic Severity of Inflammatory Bowel Disease: A Systematic Review and Critical Appraisal Get access

• Abstract
• Lay summary
• Supplementary data

Improving Brain–Gut Studies in Crohn’s Disease: Methodological Considerations Get access

• Extract

Mechanosensitive Ion Channel PIEZO1 as a Key Regulator of Intestinal Fibrosis in Crohn’s Disease Get access

• Abstracts
• Lay summary
• Supplementary data

Placental Transfer of Upadacitinib Among Pregnant Women with Inflammatory Bowel Disease Get access

• Extract

Erythrocyte Methotrexate–Polyglutamate Concentrations in Pediatric Inflammatory Bowel Disease

• Abstract
• Lay summary
• Supplementary data

Bridging the Gap Between Explanatory and Pragmatic Trials in Inflammatory Bowel Disease Get access

• Extract

Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA^®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS

• Abstract
• Lay summary
• Supplementary data

Letter: Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: Authors’ Reply Get access

• Extract

Advancing Toward Transmural Healing in Pediatric Crohn’s Disease Get access

• Extract

Eco-gastroenterology in Inflammatory Bowel Disease Treatment: A Call for Sustainable Healthcare Get access

Long-Term Course and Prognostic Factors in Pediatric Ulcerative Proctitis: A Multicenter Cohort Study

• Abstracts
• Lay summary
• Supplementary data

Stricturing Crohn’s Disease: When Biologics May Help or Not? Get access

• Extract

The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

• Abstract
• Lay summary
• Supplementary data

Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis Get access

• Abstract
• Lay summary
• Supplementary data

The Effectiveness of Risankizumab as Induction Therapy for Crohn’s Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases Get access

DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease Get access

• Extract

GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD Get access

• Abstract
• Lay summary
• Supplementary data

Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn’s Disease Get access

• Abstract
• Lay summary
• Supplementary data

The Impact of Hormone Therapy on Inflammatory Bowel Disease in Transgender and Nonbinary Individuals Get access

• Abstract
• Lay summary
• Supplementary data